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Background: The prognostic significance of multiple draining basins is controversial in
melanoma because analyses have not adequately controlled for standard prognostic
variables. We hypothesized that an analysis based on prognostically matched pairs of
patients with multiple versus single drainage basins would clarify any independent role
of basin number.
study design: We identified patients in our 40-year prospective database, who underwent
preoperative lymphoscintigraphy, intraoperative sentinel node biopsy and wide local excision for cutaneous melanoma. Overall survival (OS), disease-specific survival (DSS), and
disease-free survival (DFS) were compared in patients with multiple versus single drainage
basins after matching by age, sex, Breslow depth, primary site, and stage at diagnosis.
results: We identified 274 patients with multibasin drainage and 1,413 patients with
single draining lymph node basins. Matching yielded 259 pairs (226 trunk, 27 head/neck,
6 extremity). Among matched pairs, multibasin drainage did not affect rates of lymph
node metastasis (p = 0.84), OS (p = 0.23), DSS (p = 0.53), overall recurrence (p = 0.65),
locoregional recurrence (p = 0.58), or distant recurrence (p = 1.0). Multivariable analysis
linked higher T stage, ulceration, older age, and lymph node positivity to decreased
DSS (p < 0.01) and DFS (p < 0.001). Number of drainage basins was not significant on
univariable or multivariable analysis.
conclusion: This analysis, the first to match for standard prognostic factors, suggests
that multiplebasin drainage as identified by lymphoscintigraphy has no independent
biological or prognostic significance in primary cutaneous melanoma.
Keywords: melanoma, multiple lymph node basin, sentinel lymph node biopsy, prognosis, survival rate

INTRODUCTION
Since the advent of lymphoscintigraphy for cutaneous melanoma it has become clear that some
primary lesions will drain to more than one lymph node basin (1, 2). Reported rates of multibasin
drainage (MBD) are 17–31% and vary related to the location of the primary lesion (3–6). Cutaneous
melanomas of the truncal region are most likely to have MBD followed by lesions of the head and
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neck, and rarely extremity lesions (3). Although sentinel lymph
node (SLN) biopsy is recommended for each basin identified during lymphatic mapping (7), the prognostic significance of MBD
is unclear.
In the multi-institutional randomized Sunbelt Melanoma trial
(3), 351 patients with MBD did not have worse outcomes; in fact
their rate of locoregional recurrence was lower than that of the
1,709 patients with single draining lymph node basins. However,
a more recent series reported a higher rate of locoregional recurrence, shorter disease-free survival (DFS), and worse melanomaspecific survival in 1,400 patients with MBD (6). Results of
smaller studies also are conflicting (4, 5, 8, 9).
Our 1997 report showed that survival was worse in 120
patients with dual-basin metastasis than in 124 patients with the
same melanoma burden confined to a single basin (7). Dual-basin
metastasis was associated with palpable nodes in 75% of first dissected basins and 43% of second dissected basins. Additionally,
the number of tumor-involved nodes was higher in patients with
dual-basin metastasis than in those with single basin metastasis.
However, this study predated the widespread use of lymphoscintigraphy or SLN biopsy and all patients received regional lymph
node dissections. In an effort to add to the current literature
regarding the prognostic significance of MBD found with lymphatic mapping of cutaneous melanoma, we have reviewed our
experience with this clinical scenario in the modern era. Unlike
other retrospective studies, we used a matched-pair analysis to
minimize bias in evaluating the true clinical significance of MBD
in cutaneous melanoma.

The surgical procedure begins with intradermal injection of
approximately 1 cc of 1% isosulfan blue dye (Lymphazurin) around
the cutaneous melanoma biopsy site. Sentinel nodes are located
intraoperatively with a gamma probe as well as by identifying and
following the blue-stained lymphatic channels. Maximum in vivo
and ex vivo radioactive counts of the sentinel node(s) and post
biopsy basin counts are evaluated and recorded to ensure that all
sentinel nodes have been excised. Sentinel nodes are sent to the
department of pathology for evaluation of paraffin-fixed sections.
Our study included patients whose primary melanomas
drained into basins in the cervical, supraclavicular, axillary, and
inguinal chains. Supraclavicular nodes were only included as a
separate lymph node basin for patients with melanomas of the
upper back, trunk, and shoulder. It has been shown that 6–15%
of melanomas in this area can have separate and distinct drainage patterns to both the axillary and/or supraclavicular nodes
(13, 14). For head and neck melanomas, supraclavicular nodes
were considered part of the cervical chain and not recorded as a
separately draining lymph node basin. Epitrochlear and popliteal
nodes were not considered separate basins from ipsilateral axillary and inguinal lymph node basins, respectively.

Matching and Statistical Analysis

Patients with incomplete data on age, sex, Breslow depth, T stage,
primary site, nodal status, and patients with mucosal melanomas
were excluded from the study. The remaining patients were
categorized into those who had single versus multiple draining
lymph node basins identified on the lymphoscintigram and during definitive operation. These patients were matched 1:1 by sex,
anatomic site of primary melanoma, Breslow depth, age, and stage
at diagnosis. Groups were compared before and after matching
using the Chi-square test and ANOVA to determine if matching
had been successful. Logistic regression was used to evaluate the
significance of multiple lymph node basins, site of primary melanoma, Breslow depth, ulceration, and patient age as indicators of
lymph node metastasis in the matched groups.
Our primary end points were overall survival (OS), diseasespecific survival (DSS), and DFS. Secondary endpoints included
total recurrence, locoregional recurrence, and distant recurrence
rates. Demographic and prognostic variables were compared by
univariable and multivariable analyses using logistic regression to
identify factors that may contribute to worse prognosis. Survival
curves were constructed using the Kaplan–Meier log-rank test.
Significance was set at p < 0.05.

MATERIALS AND METHODS
The melanoma database at the John Wayne Cancer Institute
(JWCI) has been prospectively maintained for 40 years. Patients
have signed written informed consent giving permission to collect
tissue, blood, and clinical data for this database. Approval from
the JWCI institutional review board was obtained for the current
retrospective review and waived the need for additional informed
consent for this study. We queried the database to identify all
patients who underwent preoperative lymphoscintigraphy and
sentinel node biopsy (SNB) for clinically localized melanoma.
The study period was January 1991 to December 2010.

Preoperative Lymphoscintigraphy and
Intraoperative Lymphatic Mapping

We have previously reported the technical details of lymphoscintigraphy and SNB at the JWCI (10, 11). However, some
details have changed slightly over time due to technological
and pharmacologic improvements (12). Lymphoscintigraphy is
performed approximately 2–4 h prior to the operative procedure.
The operating surgeon marks the primary melanoma site (or the
site of prior wide excision) and the patient is sent to the department of nuclear medicine, where filtered technetium 99mTc sulfur
colloid (0.5 mCi) is injected into the skin around the marked
lesion. Sequential images from a scintillation camera are used to
identify the sentinel lymph nodes and the sites are marked on the
overlying skin.

Frontiers in Oncology | www.frontiersin.org

RESULTS
Review of our database revealed 274 patients with multiple
draining lymph node basins and 1,413 patients with single
draining lymph node basins as identified by lymphoscintigraphy.
Matching of these two groups yielded 259 pairs. Comparison of
the matched pairs revealed that patient and tumor characteristics
were similar for all matching statistics (p ≥ 0.84, Table 1).
Matched single basin drainage (SBD) and MBD groups each
had 259 patients with 226 truncal lesions, 27 head and neck lesions,
and 6 extremity lesions. Mean follow-up for matched groups was
80.9 months. All patients in the MBD group had two or three
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Table 1 | Patient demographics.

Table 2 | Sentinel lymph node (SLN) status for each individual draining basin in
259 matched patients with multiple draining lymph node basins.

Matched

Patients
Sex
Male
Female
Stage (presentation)
I/II
III
T stage
Unknown
T1
T2
T3
T4
Site of primary
Extremity
Head/neck
Trunk
Age
0–9
10–19
20–29
30–39
40–49
50–59
60–69
70–79
80+
Sentinel lymph node
Positive
Negative

One basin

Multiple basins

259

259

p Value

Basins mapped

Positive SLN

2

0 basins
1 basin
2 basins
0 basins
1 basin
2 basins
3 basins

0.92
192
67

191
68

3
0.922

188
71

187
72

8
101
83
50
17

7
101
83
49
19

6
27
226

6
27
226

0
5
15
35
58
65
47
22
12

1
5
17
39
52
58
51
26
10

0.989

Total

0.949

67 (25.9%)
192 (74.1%)

Draining basinsa
One versus multi-basin
T stagea
T1: 0.01–1.00
T2: 1.00–2.00
T3: 2.01–4.00
T4: >4.00 (ref)
Ulcerationa
Yes versus no
Unknown versus no

p = 0.8402

Agea
Sentinel lymph node (SLN) positivea

draining basins (Table 2). MBD basins were located bilaterally in
186 patients (67.6%) and unilaterally in 89 patients (32.4%). SLN
positivity was 25% (n = 65) in the single basin group and 26%
(n = 67) in the multiple basin group (p = 0.84). Of the patients with
MBD and SLN metastasis, 45 patients had a positive SLN in only one
of the two basins, 16 had positive SLN in the two separate basins, 1
patient had positive SLN in 2 of the 3 basins, and 5 patients had a
positive SLN in 1 of the 3 basins (Table 2). There was no difference
in the mean number of positive nodes for patients with single basin
(1.303) versus multiple basins (1.397) drainage (p = 0.5).
There was no significant difference in 10-year OS between the
matched groups (p = 0.23, Figure 1A). Ten-year OS was 80.3%
(CI: 0.75–0.85) for the single basin group compared to 75.7% (CI
0.70–0.81) for the multiple basin group. There was no difference in
10-year OS between the two groups that were either SLN negative
(p = 0.579, Figure 1B) or SLN positive (p = 0.208, Figure 1C).
SLN-positive patients showed no difference in 10-year OS whether
they had positive nodes in single or multiple basins (Figure 1D).
Similarly, DSS also showed no difference between the matched
groups (p = 0.529, Figure 2). Ten-year DSS was 86.1% for the
single basin group and 84.2% for the MBD group. Factors that
were predictive of 10-year OS on multivariable analysis between
the matched groups included Breslow depth, ulceration, positive
SLN, and age (p ≤ 0.008 for all variables). Multiple draining
lymph node basins did not reach significance as a predictor of
OS on multivariable analysis (p = 0.129, Table 3).
Frontiers in Oncology | www.frontiersin.org

Frequency (%)

181
45
16
11
5
1
0

69.9
17.4
6.18
4.25
1.93
0.39
0.0

259

100

Table 3 | Univariable and multivariable analyses of predictors of 10-year overall
survival for matched cohorts.
1.0

65 (25.1%)
194 (74.9%)

N

Univariable

Multivariable

HR (95% CI)
p Value

HR (95% CI)
p Value

0.82 (0.57–1.18)
0.283

0.75 (0.51–1.09)
0.129

0.10 (0.05–0.21)
0.42 (0.25–0.72)
0.70 (0.40–1.22)
<0.0001

0.17 (0.08–0.36)
0.50 (0.29–0.86)
0.74 (0.42–1.29)
<0.0001

3.56 (2.40–5.28)
2.95 (1.59–5.48)
<0.0001
1.04 (1.02–1.05)
<0.0001
2.57 (1.78–3.72)
<0.0001

1.86 (1.22–1.83)
1.57 (0.80–3.09)
0.015
1.04 (1.02–1.05)
<0.0001
2.05 (1.38–3.04)
0.0004

Sitea
Extremity
Head/neck
Trunk (ref)

0.40 (0.06–2.86)
1.64 (0.99–2.71)
0.097^

NS

Sexa
Male versus female

1.12 (0.73–1.71)
0.61

NS

Stage III versus I/II

3.11 (2.15–4.48)
<0.0001

–

a
Number of draining basins, T stage, ulceration, age, SLN positive, site, and sex are
included in the stepwise model selection for multivariate analysis. Stage was not included
in the stepwise model selection and therefore multivariable analysis is not applicable.

Ten-year DFS revealed no difference between the matched
groups (p = 0.64, Figure 3). Forty-four patients (17%) in the single
basin group and 48 patients (18.5%) in the multiple basin group
developed locoregional or distant recurrence (p = 0.65). There
were 28 locoregional (10.8%) recurrences for the SBD group and
32 (12.4%) for the MBD group (p = 0.58). Both groups had 16
patients (6.2%) with distant recurrence (p = 1.0, Table 4). When
evaluated by SLN status, there was no difference in recurrence
rates for patients with a positive node in single (30.8%) or multiple
(35.8%) draining basins (p = 0.54). This was also true for locoregional recurrences (p = 0.25) and distant recurrences (p = 0.53).

DISCUSSION
Although other reports have shown that number of drainage basins
from primary cutaneous melanoma does not affect survival (3, 4),
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Figure 1 | (A) Ten-year overall survival for matched patients who had single basin drainage (SBD) and multibasin drainage (MBD). Survival is also shown for (B)
matched subgroups with tumor-negative sentinel lymph nodes (SLNs) and (C) tumor-positive SLNs. (D) Survival for SLN-positive patients is further categorized by
single basin versus multibasin metastases.

Figure 2 | Ten-year disease-specific survival for matched patients who had
single versus multiple draining lymph node basins.

Figure 3 | Ten-year disease-free survival for patients who had single versus
multiple draining lymph node basins and were matched by standard
prognostic factors.

ours is the first study to match MBD and SBD groups by patientrelated and tumor-related prognostic variables. The importance
of prognostic matching is demonstrated by critical evaluation
of studies that reported a survival impact of MBD but did not

Frontiers in Oncology | www.frontiersin.org

control for standard prognostic characteristics (15). For example,
one published study found MBD to have an adverse impact on
survival, independent of SLN positivity (8). However, the 76 MBD
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finding drainage to multiple basins on lymphoscintigraphy. The
nearly identical survival curves for patients with negative sentinel
nodes (Figure 1B) and for patients with positive nodes in only
one basin (Figure 1D) support this theory.
Most studies have shown that MBD does not correlate with SLN
metastasis (3, 4, 8). The clinical finding with the most variability
among studies is the rate of recurrence for patients with MBD. Several
institutions have reported increased recurrence rates for patients
with multiple basins (6, 8, 9), while one showed worse recurrence
rates for patients with a single draining basin (3). We found that
number of drainage basins did not affect DFS, overall recurrence,
locoregional, or distant recurrence, regardless of SLN status.
Whether the phenomenon of MBD is purely based on anatomical location of the primary tumor or influenced by tumor biology
remains unknown. Biologic factors that could theoretically
increase the likelihood of multibasin drainage include ulceration, regression, lymphatic clogging, or possibly “collateral route”
spread as a result of lymphangiogenesis induced by the primary
tumor (8). Additionally, it has been suggested that tumors with
MBD may be predisposed to distant, blood-borne metastases (8).
Our findings do not rule out these hypotheses but do demonstrate
that once appropriately controlled, the rate of developing distant
metastases was identical between the two groups.
Despite our long follow-up and best efforts to minimize bias,
the limitations of a single-institution retrospective study remain.
Pathological findings including mitoses, ulceration, and regression were not routinely reported during our study period and
were therefore not used to correlate survival or recurrence for
the two groups. We are unable to comment on the independent
significance of MBD on SLN metastasis in our matched groups
since stage at presentation (which integrates the results of SNB)
was one of the matching criteria and thus both groups had the
same number of patients with regional microscopic metastases
at presentation. By using stage at presentation as a matching
criterion, we could compare long-term survival and recurrence
data for two large groups of very similar patients. Had patients
not been matched by stage, a disproportionate distribution of
stage I/II and stage III cases could have biased survival and
recurrence data. While multivariable analysis, and not matching, may be the standard method of retrospectively evaluating
two groups to correct for confounders and population heterogeneity, all previous studies of MBD have used these methods
with conflicting results (3–6, 8, 9, 20). Given the inconsistent
conclusions found with multivariable analysis, we hope to
bring a new perspective to this clinical scenario by using the
alternative statistical method of base pair matching to add to the
understanding of the true prognostic value of MBD when found
on lymphoscintigraphy.
Unlike several other studies, our data show no difference in OS
or DFS of patients whose primary cutaneous melanoma drains to
single versus multiple nodal basins (5, 6, 8, 9). This is the first study
to evaluate this clinical scenario in a matched-pair analysis. MDB
may only be a factor for 10-year OS for the small group of patients
who have multiple SLN-positive basins compared to patients with
the same disease burden in a single basin but our study is not
powered to definitively make these conclusions. Our data suggests that the clinical finding of MDB on lymphoscintigraphy

Table 4 | Comparison of 10-year overall survival (OS), disease-specific survival
(DSS), disease-free survival (DFS), sentinel lymph node (SLN) positivity, and
recurrence rates between matched patients with single versus multiple draining
lymph node basins.
Single
10-year OS
10-year DSS
10-year DFS
SLN+
Recurrence (total)
Locoregional
Distant
Recurrence (total)
Locoregional
Distant

80.3%
86.1%
83.0%
65 (25.1%)
20 (30.8%)
12 (18.5%)
8 (12.3%)
44 (17.0%)
28 (10.8%)
16 (6.2%)

Multiple
75.7%
84.2%
81.5%
67 (25.9%)
24 (35.8%)
18 (26.9%)
6 (9.0%)
48 (18.5%)
32 (12.4%)
16 (6.2%)

p-Value
0.23
0.53
0.64
0.84
0.54
0.25
0.53
0.65
0.58
1.0

patients had a significantly higher percentage of males and a nonsignificantly higher rate of thick (>4 mm) primaries than the 190
SBD patients. These imbalances might have contributed to the
worse survival in the MBD group (16, 17). Similarly, another study
linked MBD to a higher risk of lymph node metastases, but average
Breslow thickness was non-significantly greater in MBD patients
than SBD patients (5). It is known that melanomas located in different locations may have different behavior. Specifically head and
neck melanoma have been shown to have poor survival and truncal
melanomas are more likely to have positive sentinel nodes (15, 18).
This is particularly important to this study as melanomas in these
areas are the most likely to have MDB. By matching, we are able to
compare patients with melanomas from the same anatomic areas
and avoid comparing tumors from two different locations that may
inherently have a different biology that could confound our results.
The data from the current study support no difference in survival for patients with SDB compared to MDB when matched by
standard histopathologic prognostic factors. Ten-year OS curves
for matched SLN-negative patients are very similar (Figure 1B).
There is also no difference in 10-year OS for patients with single
versus multiple draining basins that were sentinel node positive.
However, while not statistically significant these curves do begin
to show some separation at 10 years (Figure 1C), suggesting that
perhaps a subset of MDB patients with SLN metastasis may have
worse survival—we believe it is likely that those with metastases
to be multiple basins (19). When 10-year OS is evaluated by the
number of basins with a positive SLN (Figure 1D), the curves
between patients with a single positive basin and multiple positive
basins appear distinct, suggesting that patients with positive SLN
in multiple basins may represent a subgroup of MDB patients
with worse 10-year OS. While not reaching significance in the
current study, this hypothesis is consistent with our previous study
of patients with metastases in multiple basins, which concluded
that the same total tumor burden of the regional nodes will carry
a worse prognosis if it involves more than one lymphatic drainage
basin (7). While having MBD on lymphoscintigraphy may not
be a poor prognostic finding, it has been shown to be prognostically worse to have either microscopic or palpable positive nodes
in multiple basins as compared to the same number of positive
nodes in a single basin (7, 19). Thus having metastases in multiple
basins may be the true indicator of poor prognosis, not simply

Frontiers in Oncology | www.frontiersin.org

5

August 2017 | Volume 7 | Article 172

Howard et al.

Multibasin Nodal Drainage in Melanoma

does not necessarily portend a worse prognosis when compared
to patients with similar primary tumors and only one draining
basin. When patients have multiple draining lymph node basins
from a primary cutaneous melanoma, each basin should be
treated according to the standard of care and physicians can
appropriately counsel patients based on the findings of SNB, primary tumor characteristics, and patient demographics in regard
to treatment, surveillance, and prognosis.
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